Warning letter
Bond Pharmacy, Inc. dba Advanced Infusion Solutions: warning letter of Mar 1, 2017
FDA warning letter 497408 · New Orleans District Office
Key facts
| Reference number | 497408 |
|---|---|
| Company | Bond Pharmacy, Inc. dba Advanced Infusion Solutions |
| Subject | Drug/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Mar 1, 2017 |
| Posted date | Mar 17, 2017 |
| Issuing office | New Orleans District Office |
| Product type | Drugs |
| Inspection city | Ridgeland |
| Inspection ZIP | 39157 |
| Inspection start date | Sep 15, 2015 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: